We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West’s Global 2016 Internship Program has, once again, quickly come to a close. This year a group of over 40 interns, chosen from a pool of 1,156 applicants, provided a wealth of knowledge, new perspectives, and unique strengths and skill sets to the business. Interns were placed at our West locations around the globe.
West’s Global 2016 Internship Program has, once again, quickly come to a close. This year a group of over 40 interns, chosen from a pool of 1,156 applicants, provided a wealth of knowledge, new perspectives, and unique strengths and skill sets to the business. Interns were placed at our West locations around the globe.
West’s internships give students the opportunity to delve into a wide array of disciplines and projects. These interns work alongside our industry experts and tackle projects where they have the potential to make an impact on West’s future, while increasing their own business acumen.
Priyansha Chadha, our Scottsdale facility’s Lean intern, ran a metrology staffing analysis enabling our QA team to plan for the next five years. Our Exton facility’s Analytical Lab Services interns, Keenan Pearson and Samantha Sholes, used preparative gas chromatography to test the purity of samples which will help prepare West for stricter FDA regulation guidelines. Finally, our Israel facility’s intern, Evyatar Ofir, had the chance to work on the implementation of West’s Product Lifecycle Management System.
“My time at West taught me how the design and manufacturing elements for pharmaceutical packaging and delivery systems and science come together to create a comprehensive solution,” said Exton’s Analytical Laboratory intern, Keenan Pearson. “I am excited to apply what I learned from my internship at West to my future educational and professional endeavors.”
Employees were especially impressed with the engagement from this year’s team of interns. It was evident that they gained an appreciation of West’s collaborative corporate culture, built confidence in their ability to communicate with all levels of the business, and established a concrete understanding of West’s role in the pharmaceutical industry. The 2016 interns demonstrated great proficiency in working on complex, biotechnical and biosimilar data analysis projects, strategic marketing research, and development of scientific methodology.
“We are grateful for the contributions that all of this year’s interns brought to West,” said Annette Favorite, Sr. VP and Chief Human Resources Officer. “We benefitted from their diverse skill sets and insight into important ongoing and new Company projects. We hope that this program has allowed them to expand upon what they are learning in the classroom to better prepare them for the world of work.”
Learn more about West’s Ambassador Internship Program here.
<em>Since 2007, West team members in Jersey Shore and Williamsport, Pa., have donated to Camp Victory, helping to beautify the grounds each year, build a wheel-chair accessible tree-house and provide funding for the summer camp experience of a lifetime for children with illnesses. For West’s Jeff Adams, </em><em class="ms-rteThemeForeColor-2-2">Supply Chain Manager/Lean Leader</em><em><span class="ms-rteThemeForeColor-2-2">,</span> Camp Victory has also been a place his family has experienced as both volunteers and campers.</em>
<p>In 2015, West Pharmaceutical Services, Inc. (West) announced that two materials of construction of the West STERI<span>LIZABLE</span>BAG™ packaging system will change:</p><ul><li>DuPont announced improvements to the manufacturing of Tyvek® 1073B Medical Packaging Material (using latest flash-spinning technology).</li><li>West’s polyethylene supplier announced discontinuation of current product.</li></ul>
When it comes to choosing the right container closure system, a significant amount of focus is directed at addressing issues that may be a risk to safety and efficacy of the parenteral drug before it is introduced to a patient. Examples are testing of container closure integrity (CCI) and drug stability. Prior to drug administration by a health care professional, the rubber stopper is pierced with a needle, at least once. Stopper puncture testing also needs to be considered, especially if the closure system will be used in a multi-dose application.
To reduce and detect particulate matter is a shared responsibility between Container Closure component suppliers and the pharmaceutical industry. Keeping the patient´s safety in mind, lively discussions about particle inspection were held in the panel session at the PDA Conference on Freeze Drying Technologies.
The FDA recognizes that compounded drugs serve an important role for patients whose medical needs cannot be met by FDA-approved drugs. However, compounded drugs are not approved by the FDA and therefore, have not been evaluated for safety or efficacy. Poor compounding practices or unsuitable manufacturing conditions can lead to serious adverse effects, or even patient death. Over the past few years, the FDA has taken significant steps to modernize and clarify policies related to the quality of compounding in an effort to ensure continued access to compounded drugs, while also protecting patients from the risks of contaminated or otherwise harmful products<sup>1</sup>. FDA Draft Guidances<sup>2, 3</sup> help to clarify applicable regulatory requirements and specifically address the use and handling of container closure systems.
English
Chinese
